BIOMAT Database Logo BIOMAT Database Logo

[Clinical evaluation of Acetyldigitoxinum Polfa in children]. 1970

T Lewenfisz-Wojnarowska, and D Jarzebska, and D Lisicka, and K Kubicka, and L Sztymirski

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D011014 Pneumonia Infection of the lung often accompanied by inflammation. Experimental Lung Inflammation,Lobar Pneumonia,Lung Inflammation,Pneumonia, Lobar,Pneumonitis,Pulmonary Inflammation,Experimental Lung Inflammations,Inflammation, Experimental Lung,Inflammation, Lung,Inflammation, Pulmonary,Inflammations, Lung,Inflammations, Pulmonary,Lobar Pneumonias,Lung Inflammation, Experimental,Lung Inflammations,Lung Inflammations, Experimental,Pneumonias,Pneumonias, Lobar,Pneumonitides,Pulmonary Inflammations
D001775 Blood Circulation The movement of the BLOOD as it is pumped through the CARDIOVASCULAR SYSTEM. Blood Flow,Circulation, Blood,Blood Flows,Flow, Blood
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004074 Digitoxin A cardiac glycoside sometimes used in place of DIGOXIN. It has a longer half-life than digoxin; toxic effects, which are similar to those of digoxin, are longer lasting. (From Martindale, The Extra Pharmacopoeia, 30th ed, p665) Coramedan,Digimed,Digimerck,Digitaline Nativelle,Digitoxin AWD,Digitoxin Bürger,Digitoxin Didier,Digitoxin-Philo,Digophton,AWD, Digitoxin,Bürger, Digitoxin,Didier, Digitoxin,Digitoxin Philo,Nativelle, Digitaline
D004361 Drug Tolerance Progressive diminution of the susceptibility of a human or animal to the effects of a drug, resulting from its continued administration. It should be differentiated from DRUG RESISTANCE wherein an organism, disease, or tissue fails to respond to the intended effectiveness of a chemical or drug. It should also be differentiated from MAXIMUM TOLERATED DOSE and NO-OBSERVED-ADVERSE-EFFECT LEVEL. Drug Tolerances,Tolerance, Drug,Tolerances, Drug
D006330 Heart Defects, Congenital Developmental abnormalities involving structures of the heart. These defects are present at birth but may be discovered later in life. Congenital Heart Disease,Heart Abnormalities,Abnormality, Heart,Congenital Heart Defect,Congenital Heart Defects,Defects, Congenital Heart,Heart Defect, Congenital,Heart, Malformation Of,Congenital Heart Diseases,Defect, Congenital Heart,Disease, Congenital Heart,Heart Abnormality,Heart Disease, Congenital,Malformation Of Heart,Malformation Of Hearts
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

T Lewenfisz-Wojnarowska, and D Jarzebska, and D Lisicka, and K Kubicka, and L Sztymirski
Clinical evaluation of Lecyvit (POLFA).
January 1976, Polish medical sciences and history bulletin,
T Lewenfisz-Wojnarowska, and D Jarzebska, and D Lisicka, and K Kubicka, and L Sztymirski
[Clinical evaluation of digoxin "Polfa"].
October 1970, Polski tygodnik lekarski (Warsaw, Poland : 1960),
T Lewenfisz-Wojnarowska, and D Jarzebska, and D Lisicka, and K Kubicka, and L Sztymirski
[Clinical evaluation of ampicillin Polfa].
January 1973, Polski tygodnik lekarski (Warsaw, Poland : 1960),
T Lewenfisz-Wojnarowska, and D Jarzebska, and D Lisicka, and K Kubicka, and L Sztymirski
[Clinical evaluation of Dicloxacillin Polfa].
December 1975, Polski tygodnik lekarski (Warsaw, Poland : 1960),
T Lewenfisz-Wojnarowska, and D Jarzebska, and D Lisicka, and K Kubicka, and L Sztymirski
Clinical evaluation of Reladorm-Polfa.
January 1979, Materia medica Polona. Polish journal of medicine and pharmacy,
T Lewenfisz-Wojnarowska, and D Jarzebska, and D Lisicka, and K Kubicka, and L Sztymirski
[Clinical evaluation of insulin Maxirapid Polfa].
November 1972, Polski tygodnik lekarski (Warsaw, Poland : 1960),
T Lewenfisz-Wojnarowska, and D Jarzebska, and D Lisicka, and K Kubicka, and L Sztymirski
[Clinical evaluation of the preparation "Betadrin-Polfa"].
February 1969, Polski tygodnik lekarski (Warsaw, Poland : 1960),
T Lewenfisz-Wojnarowska, and D Jarzebska, and D Lisicka, and K Kubicka, and L Sztymirski
[Preliminary clinical evaluation of the preparation Fluigel-Polfa].
July 1979, Polski tygodnik lekarski (Warsaw, Poland : 1960),
T Lewenfisz-Wojnarowska, and D Jarzebska, and D Lisicka, and K Kubicka, and L Sztymirski
[Evaluation of the clinical effectiveness of cloxacillin. (Syntarpen 201 Polfa)].
August 1970, Polski tygodnik lekarski (Warsaw, Poland : 1960),
T Lewenfisz-Wojnarowska, and D Jarzebska, and D Lisicka, and K Kubicka, and L Sztymirski
[Clinical evaluation of the Undofen aerosol preparation manufactured by Polfa].
January 1976, Annales Academiae Medicae Stetinensis,
Copied contents to your clipboard!